Concepedia

Changyong Yang

CY

Statistics

Publications

14

Citations

789

H-Index

12

Active since

2009

Affiliations

Jiangsu Hengrui Medicine (China)(Current)

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

Southeast University

Southeast University

Changyong Yang is an author at Jiangsu Hengrui Medicine (China) specializing in pharmacology, medicine, and pharmacy.

ORCID

Publications per year

2009–2020

14

Publications

14

Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer

Xin Li, Changyong Yang, Hong Wan et al. · European Journal of Pharmaceutical Sciences · 2017 · 227 citations

, , +13

Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components

Changyong Yang, Jing Wang, Yuan Zhao et al. · Journal of Ethnopharmacology · 2010 · 137 citations

, , +13

Pharmacologic characterization of fluzoparib, a novel poly(<scp>ADP</scp>‐ribose) polymerase inhibitor undergoing clinical trials

Lei Wang, Changyong Yang, Chengying Xie et al. · Cancer Science · 2019 · 93 citations · Full text

, , +16

Metabolic characterization of pyrotinib in humans by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

Yunting Zhu, Liang Li, Ge Zhang et al. · Journal of Chromatography B · 2016 · 84 citations

, , +12

Effects of antimony on aquatic organisms (Larva and embryo of Oryzias latipes, Moina macrocopa, Simocephalus mixtus, and Pseudokirchneriella subcapitata)

Sun‐Hwa Nam, Changyong Yang, Youn‐Joo An · Chemosphere · 2009 · 52 citations

, , +15

1–5 of 14